Pilot corpus: NIH-funded biomedical datasets. Any DOI can be scored on demand — network effects sharpen as coverage grows.

Mixing it up: boosting responses with immunotherapy combinations

Trends in cancer(2025)10.1016/j.trecan.2025.04.013Source: DataRank Database

Mixing it up: boosting responses with immunotherapy combinations is a research paper published in Trends in cancer (2025). On theSindex it has a DataRank of 0.

N/A

0DataRank · unranked

Scored on demand from live citation data

Open Access0 citations

Download PDF

Cite:

Linked data & code

nct

DataRank reads this dataset's downstream impact straight off the citation graph — no black box, no proprietary weighting. How is this computed?

›Methodology & internals

datarank_citation_only_1hop_v6· scope data_onlyMethodology

Pipeline:MetadataData-paper checkEnrichmentCitation networkScoring

Enrichment:Funding (4 grants)Impact (FWCI 0.00)OA: greenTopics (38)IDs (PubMed, PMC, OpenAlex)Annotations (1)SDGs (1)

FAIR Checklist

Context only (not used in score)

Findable (1/2)

Has DOI

Accessible (1/2)

Open Access

Interoperable (0/2)

Reusable (0/3)

FAIR checklist signals are shown for context only and do not affect DataRank scoring.

Run a calibrated FAIR evaluation for this paper →

We only score data papers we can read in full — never from an abstract alone.

Authors (3)

Edward S. Sim ORCID,Ravindra Uppaluri ORCID,Hiroki Komatsuda ORCID

Live enrichment

PubMed:40335428 PMC:PMC12158630 OpenAlex:https://openalex.org/W4410111096

National Institute on Deafness and Other Communication Disorders

Grant: T32DC000020

NIDCR NIH HHS

Grant: R01 DE027736

National Institutes of Health

Merck

FWCI

0.00

Citation Percentile

0.1%

greenLicense: http://www.elsevier.com/open-access/userlicense/1.0/

repositoryhttps://pmc.ncbi.nlm.nih.gov/articles/PMC12158630/

publisherhttps://api.elsevier.com/content/article/PII:S2405803325001098?httpAccept=text/xml

publisherhttps://api.elsevier.com/content/article/PII:S2405803325001098?httpAccept=text/plain

journalhttps://doi.org/10.1016/j.trecan.2025.04.013

Fields of Study

Immunotherapy and Immune ResponsesImmune Cell Function and InteractionCancer Immunotherapy and BiomarkersHumansImmune Checkpoint InhibitorsAntineoplastic Combined Chemotherapy ProtocolsNeoadjuvant TherapyHead and Neck NeoplasmsProgrammed Cell Death 1 ReceptorImmunotherapyCTLA-4 AntigenTreatment OutcomeLymphocyte Activation Gene 3 ProteinBiomarkers, Tumor

MeSH Terms

Immune Checkpoint InhibitorsLymphocyte Activation Gene 3 ProteinAntineoplastic Combined Chemotherapy ProtocolsHead and Neck NeoplasmsHumansImmunotherapyBiomarkers, TumorTreatment OutcomeNeoadjuvant TherapyCTLA-4 AntigenProgrammed Cell Death 1 Receptor

Keywords

Boosting (machine learning)Mixing (physics)ImmunotherapyMedicineComputer scienceImmunologyArtificial intelligenceImmune systemPhysicsHead And Neck CancerImmune Checkpoint InhibitorNeoadjuvant ImmunotherapySingle-cell Rna Sequencing

Sustainable Development Goals

SDG 0: Zero hunger

Mixing it up: boosting responses with immunotherapy combinations

FAIR Checklist

Authors (3)

Funding (4 grants)

Impact

Open Access

Topics

Annotations (Europe PMC)